Pathophysiology of anthracycline cardiotoxicity
Key result
Anthracycline-induced cardiotoxicity is a complex, multifactorial process involving oxidative stress, topoisomerase IIβ inhibition, mitochondrial dysfunction, and disrupted iron and calcium homeostasis.
Population
Cancer patients receiving anthracyclines
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Cardiotoxicity risk persists in anthracycline therapy; leaves open genetic profiling to guide risk stratification.
Structured PICO
P
Population
Cancer patients receiving anthracyclines
I
Intervention
Anthracyclines
Anthracycline-induced cardiotoxicity remains a significant clinical challenge, emphasizing the need for better molecular characterization and genetic profiling to identify high-risk patients.
Limitations
- The molecular and cellular mechanisms underlying anthracycline-induced cardiotoxicity are still not fully characterized.
- It remains unclear how experimental findings of cardiac injury translate to the clinical setting.
Cite This Study
Mele et al. (2016) conducted a review in Anthracycline-induced cardiotoxicity. Anthracyclines was evaluated. Anthracycline-induced cardiotoxicity is a complex, multifactorial process involving oxidative stress, topoisomerase IIβ inhibition, mitochondrial dysfunction, and disrupted iron and calcium homeostasis.